Načítá se...

NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial

Patients treated with vaccines based on NGlycolil gangliosides have showed benefit in progression free survival and overall survival. These molecules, which have been observed in breast cancer cells, are minimally or not expressed in normal human tissue and have been considered as antigen tumor-spec...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: de la Torre, Ana, Hernandez, Julio, Ortiz, Ramón, Cepeda, Meylán, Perez, Kirenia, Car, Adriana, Viada, Carmen, Toledo, Darién, Guerra, Pedro Pablo, García, Elena, Arboláez, Migdacelys, Fernandez, Luis E
Médium: Artigo
Jazyk:Inglês
Vydáno: Libertas Academica 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3465086/
https://ncbi.nlm.nih.gov/pubmed/23055739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S8488
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!